Dr Jia Ruan at ASH 2014: Phase II study of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma (Part 1 of 2) - 101271

Spotlight
Video

Dr Jia Ruan at ASH 2014: Phase II study of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma (Part 1 of 2)

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Jia Ruan (Weill Cornell Medical College, New York, NY) discusses a phase II study of the biologic doublet of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma, including the trial design, efficacy and safety endpoints, and results.

Part 1: http://www.oncologytube.com...
Part 2: http://www.oncologytube.com...

This programme has been supported by sponsorship from Celgene

–––

European Medical Journal

Website: http://emjreviews.com/...
Twitter: https://twitter.com/EMJRevi...
Facebook: https://www.facebook.com/em...
Shared By : EMJ
Posted on : 04/13/15
Added : 4 years ago